Roche (OTCMKTS:RHHBY) Sets New 52-Week High – Still a Buy?

Roche Holding AG (OTCMKTS:RHHBY) hit a new 52-week high during trading on Tuesday . The company traded as high as $54.65 and last traded at $54.65, with a volume of 337384 shares trading hands. The stock had previously closed at $54.25.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Barclays upgraded shares of Roche from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 6th. Jefferies Financial Group downgraded shares of Roche from a “hold” rating to a “moderate sell” rating in a research note on Monday, October 27th. Hsbc Global Res upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a research note on Tuesday, November 11th. Finally, Morgan Stanley reissued an “underweight” rating on shares of Roche in a research note on Tuesday, December 2nd. Three investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $57.00.

Roche Stock Performance

The business’s 50-day simple moving average is $50.17 and its 200-day simple moving average is $44.47. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.29 and a quick ratio of 1.02.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. OLD National Bancorp IN increased its stake in shares of Roche by 2.9% during the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock valued at $10,604,000 after buying an additional 7,326 shares during the period. Enterprise Financial Services Corp purchased a new position in Roche during the 2nd quarter valued at $208,000. North Star Asset Management Inc. increased its position in Roche by 52.0% during the 2nd quarter. North Star Asset Management Inc. now owns 26,305 shares of the company’s stock valued at $1,072,000 after purchasing an additional 9,000 shares during the period. FineMark National Bank & Trust bought a new position in Roche in the 2nd quarter worth $210,000. Finally, Yousif Capital Management LLC lifted its position in shares of Roche by 7.8% in the 2nd quarter. Yousif Capital Management LLC now owns 88,547 shares of the company’s stock worth $3,593,000 after purchasing an additional 6,395 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.